InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,564.14
(
1.00%
)
US TECH 100
19,837.60
(
1.00%
)
Dow Jones
39,360.26
(
0.13%
)
Brent Oil
86.49
(
-0.97%
)
Bitcoin
56,406.60
(
-1.01%
)
Post# of 38376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

damsam1

Send PM Follow Ignore
Followers 7
Posts 334
Boards Moderated 0
Alias Born 06/03/2012

damsam1

Re: None

Saturday, 09/08/2012 9:13:29 AM

Saturday, September 08, 2012 9:13:29 AM

Post# of 38376
My take on the Imenvax update is a disappointing one. Although it slowed tumor growth, It failed to reduce it's size. The good news is it was recommended to continue the study, but the bad news is the expense to Entest for 12 to 14 months. If there is any value for Imenvax it will need to report the reduction of a tumor, not just slowing growth. This is why our shorty friends stuffed us during the "Rally". It will be a long wait from here.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up